McKesson Corporation (MCK) |
|
434.85 -7.19 (-1.63%)
|
09-29 16:03 |
|
Open: |
440.41 |
Pre. Close: |
442.04 |
|
High:
|
441.97 |
Low:
|
434.57 |
|
Volume:
|
679,148 |
Market Cap:
|
58,662(M) |
|
|
|
Technical analysis |
as of: 2023-09-29 4:28:55 PM |
|
Short-term rate:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 522.03 One year: 609.73 |
| Support: |
Support1: 420.85 Support2: 404.72 |
| Resistance: |
Resistance1: 446.95 Resistance2: 522.03 |
| Pivot: |
432.86  |
| Moving Average: |
MA(5): 442.14 MA(20): 428.15
MA(100): 413.14 MA(250): 385.08 |
| MACD: |
MACD(12,26): 5.8 Signal(9): 4.7 |
| Stochastic oscillator: |
%K(14,3): 78.1 %D(3): 86.9 |
| RSI: |
RSI(14): 55.1 |
| 52-week: |
High: 446.95 Low: 331.75 |
| Average Vol(K): |
3-Month: 780 (K) 10-Days: 800 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MCK ] has closed below upper band by 44.8%. Bollinger Bands are 19.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
442.5 - 445.27 |
445.27 - 447.22 |
|
Low:
|
427.95 - 431.43 |
431.43 - 433.89 |
|
Close:
|
430.31 - 435.37 |
435.37 - 438.94 |
|
Company Description |
|
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. |
Headline News |
Mon, 02 Oct 2023
Stratos Wealth Partners LTD. Buys 267 Shares of McKesson Co ... - MarketBeat
Mon, 02 Oct 2023
Should You Buy McKesson Corp (MCK) in Medical Distribution Industry? - InvestorsObserver
Fri, 29 Sep 2023
McKesson Corp. stock underperforms Friday when compared to competitors - MarketWatch
Thu, 28 Sep 2023
Louisiana State Employees Retirement System Lowers Position in ... - MarketBeat
Thu, 28 Sep 2023
Zacks.com featured highlights include Applied Materials, PulteGroup ... - Nasdaq
Wed, 27 Sep 2023
McKesson Corporation Announces Second Quarter Fiscal 2024 ... - McKesson
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Distribution |
| Shares Out. |
135 (M) |
| Shares Float |
135 (M) |
|
% Held by Insiders
|
0.1 (%) |
|
% Held by Institutions
|
87.6 (%) |
|
Shares Short
|
1,640 (K) |
|
Shares Short P.Month
|
1,590 (K) |
Stock Financials |
|
EPS
|
26.81 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-11.89 |
|
Profit Margin (%)
|
1.3 |
|
Operating Margin (%)
|
1.6 |
|
Return on Assets (ttm)
|
4.4 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
10.8 |
|
Gross Profit (p.s.)
|
91.62 |
|
Sales Per Share
|
2105.55 |
|
EBITDA (p.s.)
|
37.5 |
|
Qtrly Earnings Growth
|
33.4 |
|
Operating Cash Flow
|
5,050 (M) |
|
Levered Free Cash Flow
|
5,090 (M) |
Stock Valuations |
|
PE Ratio
|
16.21 |
|
PEG Ratio
|
1.5 |
|
Price to Book value
|
-36.61 |
|
Price to Sales
|
0.2 |
|
Price to Cash Flow
|
11.61 |
Stock Dividends |
|
Dividend
|
0.62 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0.1% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
